Affirm Holdings Valuation
Is AFRM * undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
1/6Valuation Score 1/6
Below Fair Value
Significantly Below Fair Value
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of AFRM * when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: Insufficient data to calculate AFRM *'s fair value for valuation analysis.
Significantly Below Fair Value: Insufficient data to calculate AFRM *'s fair value for valuation analysis.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for AFRM *?
Key metric: As AFRM * is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.
What is AFRM *'s PS Ratio? | |
---|---|
PS Ratio | 8.6x |
Sales | US$2.52b |
Market Cap | US$20.90b |
Key Statistics | |
---|---|
Enterprise Value/Revenue | 10.3x |
Enterprise Value/EBITDA | -89.5x |
PEG Ratio | n/a |
Price to Sales Ratio vs Peers
How does AFRM *'s PS Ratio compare to its peers?
Company | Forward PS | Estimated Growth | Market Cap |
---|---|---|---|
Peer Average | 9.4x | ||
TOST Toast | 5.2x | 17.3% | US$24.3b |
CPAY Corpay | 6.9x | 9.9% | US$26.5b |
FOUR Shift4 Payments | 2.5x | 19.5% | US$7.7b |
ADYEN Adyen | 23.1x | 18.8% | €41.8b |
AFRM * Affirm Holdings | 8.6x | 19.7% | Mex$20.9b |
Price-To-Sales vs Peers: AFRM * is good value based on its Price-To-Sales Ratio (8.6x) compared to the peer average (9.4x).
Price to Sales Ratio vs Industry
How does AFRM *'s PS Ratio compare vs other companies in the South American Diversified Financial Industry?
4 Companies | Price / Sales | Estimated Growth | Market Cap |
---|---|---|---|
4 Companies | Estimated Growth | Market Cap | |
---|---|---|---|
Price-To-Sales vs Industry: AFRM * is expensive based on its Price-To-Sales Ratio (8.6x) compared to the South American Diversified Financial industry average (1.5x).
Price to Sales Ratio vs Fair Ratio
What is AFRM *'s PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
Fair Ratio | |
---|---|
Current PS Ratio | 8.6x |
Fair PS Ratio | n/a |
Price-To-Sales vs Fair Ratio: Insufficient data to calculate AFRM *'s Price-To-Sales Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Date | Share Price | Average 1Y Price Target | Dispersion | High | Low | 1Y Actual price | Analysts |
---|---|---|---|---|---|---|---|
Current | Mex$1,417.00 | Mex$1,072.35 -24.3% | 27.9% | Mex$1,536.05 | Mex$409.61 | n/a | 17 |
Nov ’25 | Mex$888.00 | Mex$915.77 +3.1% | 25.8% | Mex$1,359.36 | Mex$399.81 | n/a | 17 |
Oct ’25 | Mex$813.00 | Mex$800.59 -1.5% | 30.3% | Mex$1,275.51 | Mex$392.46 | n/a | 16 |
Sep ’25 | Mex$864.00 | Mex$763.70 -11.6% | 30.9% | Mex$1,279.90 | Mex$393.81 | n/a | 15 |
Aug ’25 | Mex$503.99 | Mex$690.27 +37.0% | 31.7% | Mex$1,198.76 | Mex$368.85 | n/a | 14 |
Jul ’25 | Mex$563.19 | Mex$688.74 +22.3% | 30.4% | Mex$1,167.87 | Mex$359.34 | n/a | 15 |
Jun ’25 | Mex$499.55 | Mex$626.28 +25.4% | 33.5% | Mex$1,102.21 | Mex$339.14 | n/a | 15 |
May ’25 | Mex$572.00 | Mex$651.37 +13.9% | 32.1% | Mex$1,118.72 | Mex$344.22 | n/a | 17 |
Apr ’25 | Mex$580.51 | Mex$635.95 +9.6% | 35.4% | Mex$1,084.64 | Mex$216.93 | n/a | 16 |
Mar ’25 | Mex$640.05 | Mex$654.27 +2.2% | 37.8% | Mex$1,111.38 | Mex$222.28 | n/a | 18 |
Feb ’25 | Mex$676.00 | Mex$538.20 -20.4% | 52.1% | Mex$1,120.35 | Mex$103.42 | n/a | 19 |
Jan ’25 | Mex$830.00 | Mex$488.52 -41.1% | 55.8% | Mex$1,107.10 | Mex$102.19 | n/a | 18 |
Dec ’24 | Mex$649.00 | Mex$381.30 -41.2% | 40.5% | Mex$705.08 | Mex$103.18 | n/a | 19 |
Nov ’24 | Mex$311.50 | Mex$292.37 -6.1% | 35.5% | Mex$505.50 | Mex$108.32 | Mex$888.00 | 18 |
Oct ’24 | Mex$373.00 | Mex$272.11 -27.0% | 35.8% | Mex$426.84 | Mex$102.44 | Mex$813.00 | 16 |
Sep ’24 | Mex$374.50 | Mex$266.81 -28.8% | 32.5% | Mex$427.28 | Mex$102.55 | Mex$864.00 | 18 |
Aug ’24 | Mex$331.00 | Mex$247.89 -25.1% | 31.9% | Mex$405.65 | Mex$101.41 | Mex$503.99 | 18 |
Jul ’24 | Mex$278.39 | Mex$240.47 -13.6% | 30.2% | Mex$412.23 | Mex$103.06 | Mex$563.19 | 18 |
Jun ’24 | Mex$258.15 | Mex$232.59 -9.9% | 24.6% | Mex$296.32 | Mex$104.58 | Mex$499.55 | 16 |
May ’24 | Mex$178.90 | Mex$246.22 +37.6% | 23.0% | Mex$323.64 | Mex$107.88 | Mex$572.00 | 17 |
Apr ’24 | Mex$209.90 | Mex$249.11 +18.7% | 22.4% | Mex$324.40 | Mex$108.13 | Mex$580.51 | 18 |
Mar ’24 | Mex$225.20 | Mex$266.90 +18.5% | 23.3% | Mex$373.15 | Mex$111.95 | Mex$640.05 | 19 |
Feb ’24 | Mex$334.00 | Mex$335.96 +0.6% | 45.4% | Mex$856.57 | Mex$111.73 | Mex$676.00 | 19 |
Jan ’24 | Mex$187.00 | Mex$368.91 +97.3% | 44.7% | Mex$903.66 | Mex$157.16 | Mex$830.00 | 19 |
Dec ’23 | Mex$275.00 | Mex$404.89 +47.2% | 44.6% | Mex$1,003.09 | Mex$192.90 | Mex$649.00 | 19 |
Nov ’23 | Mex$405.00 | Mex$586.12 +44.7% | 35.1% | Mex$1,045.15 | Mex$295.80 | Mex$311.50 | 18 |
Analyst Forecast: Target price is lower than the current share price.
Discover undervalued companies
International Money Express
US$662.1m
Operates as an omnichannel money remittance services company in the United States, Latin America, Mexico, Central and South America, the Caribbean, Africa, and Asia.
IMXI *
US$430.00
7D
0%
1Y
n/a
3i Group
UK£35.3b
A private equity firm specializing in mature companies, growth capital, middle markets, infrastructure, and management leveraged buyouts and buy-ins.
III N
UK£905.30
7D
0%
1Y
n/a
Yiren Digital
US$421.6m
Provides financial services through an AI-powered platform in China.
YRD N
US$122.00
7D
0%
1Y
n/a